This article is more than 5 years old. Information may no longer be current.

United Orthopedic Corporation enters US market

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

United Orthopedic Corporation announced its entrance into the American market, offering cost-effective hip and knee devices through its U.S. subsidiary, United Orthopedic Corporation USA.

Headquartered in Taiwan, United Orthopedic Corporation has been supplying and supporting orthopedic practitioners and institutions around the world with arthroplasty implant and instrument designs created by its vertically integrated, in-house manufacturing team. According to a press release, its designs are based on first-hand practitioner input, as well as rigorous clinical research, and are known for meeting world quality assurance standards.

“United Orthopedic Corporation is the first Asian orthopedic company to receive FDA approval for joint reconstruction,” Calvin Lin, president of United Orthopedic Corporation USA, stated in the press release. “For the past 20 years, we have been recognized for our innovative products and we are excited to bring our high-performing line of hip and knee replacement systems to American orthopedic surgeons.”